Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITION CONTAINING DECURSIN OR DECURSINOL ANGELATE FOR TREATING ANGIOGENESIS-RELATED DISEASES
Document Type and Number:
WIPO Patent Application WO/2010/008129
Kind Code:
A1
Abstract:
The present invention is a composition which contains a decursin or decursinol angelate as an active ingredient for preventing or treating diseases which are related to angiogenesis induced by a VEGF (Vascular Endothelial Growth Factor). The decursin and decursinol angelate in the present invention can prevent and treat diseases which are related to VEGF-induced angiogenesis by blocking ERK (Extracellular Signal-Regulated Kinase )- and JNK (c-Jun N-terminal Kinase)-MARK (Mitogen-Activated- Protein Kinase)-activated signal transduction and suppressing MMP-2 (Matrix Metalloproteinase-2) activation through inhibition of VEGFR-2 (Vascular Endothelial Growth Factor Receptor-2) phosphorylation.

Inventors:
LEE YOU MIE (KR)
Application Number:
PCT/KR2009/001800
Publication Date:
January 21, 2010
Filing Date:
April 08, 2009
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KYUNGPOOK NAT UNIV IND ACAD (KR)
LEE YOU MIE (KR)
International Classes:
A61K31/37
Domestic Patent References:
WO2000023074A12000-04-27
WO2005123063A12005-12-29
WO2001052841A12001-07-26
Foreign References:
KR20080004332A2008-01-09
KR20050017630A2005-02-22
KR20060078343A2006-07-05
US20070264370A12007-11-15
KR20060066174A2006-06-16
KR20060066175A2006-06-16
KR20060066176A2006-06-16
KR20060066177A2006-06-16
Other References:
RANA P SINGH ET AL.: "Mechanisms of action of novel agents for prostate cancer chemoprevention.", ENDOCRINE-RELATED CANCER., vol. 13, no. 3, 2006, pages 751 - 778
CHENG JIANG ET AL.: "Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.", BREAST CANCER RESEARCH., vol. 9, no. 6, 2007, pages R77
Attorney, Agent or Firm:
KIM, SOON-WOONG (KR)
κΉ€μˆœμ›… (KR)
Download PDF: